Spread | 3.0 | ||||
Long position overnight fee Long position overnight fee
Trade size with leverage ~ SEK 5,000.00 Short position overnight fee ~ SEK 4,000.00 | -0.021938% | ||||
Short position overnight fee Short position overnight fee
Trade size with leverage ~ SEK 5,000.00 Short position overnight fee ~ SEK 4,000.00 | -0.000284% | ||||
Overnight fee time | 21:00 (UTC) | ||||
Currency | SEK | ||||
Min traded quantity | 1 | ||||
Margin | 20 | ||||
Stock exchange | Sweden | ||||
Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
Prev. Close | 165.6 |
Open | 166.8 |
1-Year Change | -26.71% |
Day's Range | 164 - 167 |
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
BRIEF: For the fiscal year ended 31 December 2021, Vitrolife AB revenues increased 35% to SEK1.68B. Net income applicable to common stockholders increased 19% to SEK341M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share remained flat at SEK0.80. Basic Earnings per Share excluding Extraordinary Items increased from SEK2.64 to SEK2.97.
1999: Stock Split in the ratio 1:2. 5/2018, 5-for-1 stock split (Factor: 5).